Roper 4Q Net Slips, Forecasts 2026 Revenue Growth

Dow Jones
Jan 27
 

By Rob Curran

 

Roper Technologies said fourth-quarter net income fell as gains on investments were less substantial than a year earlier, but the software maker logged brisk revenue growth and forecast higher demand this year.

The Sarasota, Fla., technology conglomerate on Tuesday posted earnings of $428.4 million or $3.97 a share, down from $462.3 million, or $4.28 a share, a year earlier.

Stripping out certain one-off items, Roper registered adjusted earnings of $5.21 a share, surpassing the average Wall Street target of $5.14 a share, as per FactSet.

Revenue rose 10% to $2.06 billion, just shy of the mean analyst estimate of $2.08 billion, according to FactSet.

For 2026, Roper, which makes specialized software for medical and other applications, targeted adjusted per-share earnings in a range between $21.30 and $21.55.

Overall, the company expects revenue to rise about 8% in 2026 from $7.9 billion in 2025. On an organic basis, excluding the impact of acquisitions and other factors, Roper anticipates revenue growth between 5% and 6%.

For the first quarter, the tech company projected adjusted earnings of $4.95-to-$5 a share.

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

January 27, 2026 07:33 ET (12:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10